Back
Day Range
$21.35
$21.38
52-Week Range
$5.64
$21.44
Volume
1,702,720
50D / 200D Avg
$13.48
/
$9.02
Prev Close
$21.44
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -20.6 | 0.4 |
| P/B | 5.0 | 2.9 |
| ROE % | -22.7 | 3.8 |
| Net Margin % | -67.9 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -104.08M
Capital efficient — spends only 0.20% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)20.60%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-22.74%
ROIC-21.58%
Net Margin-67.85%
Op. Margin-80.76%
Safety
Debt / Equity
0.01
Current Ratio8.02
Interest Coverage0.00
Valuation
P/E Ratio
-20.56
P/B Ratio5.00
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.60% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 158.18M | Net Income (TTM) | -107.32M |
| ROE | -22.74% | ROA | -21.13% |
| Gross Margin | 89.12% | Operating Margin | -80.76% |
| Net Margin | -67.85% | Free Cash Flow (TTM) | -104.08M |
| ROIC | -21.58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 8.02 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -20.56 | P/B Ratio | 5.00 |
| P/S Ratio | 13.95 | PEG Ratio | -4.58 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.21B | Enterprise Value | 2.01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 158.18M | 131.16M | 0.0 | 0.0 | 0.0 |
| Net Income | -107.32M | -95.50M | -188.92M | -142.18M | -70.65M |
| EPS (Diluted) | -1.04 | -1.02 | -2.37 | -2.02 | -1.14 |
| Gross Profit | 140.97M | 125.88M | -383,000.0 | -531,000.0 | -199,000.0 |
| Operating Income | -127.75M | -217.27M | -206.06M | -146.91M | -72.74M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 507.83M | 582.79M | 376.05M | 349.06M | 289.82M |
| Total Liabilities | 66.67M | 80.04M | 29.51M | 17.02M | 8.67M |
| Shareholders' Equity | 441.16M | 502.75M | 346.54M | 332.04M | 281.15M |
| Total Debt | 2.79M | 2.60M | 408,000.0 | 813,000.0 | 220,000.0 |
| Cash & Equivalents | 197.08M | 124.97M | 230.78M | 85.26M | 284.31M |
| Current Assets | 485.10M | 562.33M | 375.27M | 347.87M | 289.37M |
| Current Liabilities | 60.52M | 73.45M | 29.51M | 16.62M | 8.66M |